US Patent Issued to Dana-Farber Cancer Institute on June 17 for "Pyrimidines as EGFR-inhibitors and methods of treating disorders" (South Korean, American Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,037, issued on June 17, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Pyrimidines as EGFR-inhibitors and methods of treating disorders" was invented by Nathanael S. Gray (Boston), Pasi Janne (Needham, Mass.), Hwan Geun Choi (Daegu, South Korea) and Jaebong Jang (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The application relates to a compound having Formula (I):which modulates the activity of EGFR, a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease in which EGFR plays a role."

The patent was filed on April 28, 2023, under Application No. 18/309,164.

*For further informati...